06 Jun 2022 --- Gelesis, maker of Plenity – an FDA-cleared weight management treatment – has presented new preclinical data evidencing its product’s efficacies. In particular, its research examines weight loss and additional metabolic benefits in mice receiving a microbiota transplant from another group of mice, treated with one of its proprietary hydrogels. These metabolic benefits occurred while both groups of mice – the donors of the microbiota transplant and the mice receiving the microbiota transplant – were on a high fat, high carbohydrate diet typically causing rapid weight gain, obesity and diabetes, as a control measure.
